Irinotecan (HCl Trihydrate) Overview Categories 8 Antineoplastics, immunomodulators and drugs used in palliative care8.2 Cytotoxic (anti-neoplastic) drugs Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Irinotecan (HCl Trihydrate) Manufacturers of Irinotecan (HCl Trihydrate) Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Irinotecan (HCl Trihydrate)'s dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 125 to 350 mg/sq.meter240 (237.5)As recommended.IV InfAs recomemnted,Over30-90 min., every 3-4 week Paedriatic Dosage (20kg) Not recommended in this age group Neonatal Dosage (3kg) Not recommended in this age group High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Irinotecan (HCl Trihydrate) Back to top Manufacturers of Irinotecan (HCl Trihydrate) in Pakistan Atco CCL Medinet Novartis ONCOGENE Pfizer Back to top Previous Drug Generic - Next Drug Generic